NCT07638241 Agentic AI Personalized Dietary Management Study
| NCT ID | NCT07638241 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Dietary Behavior; Metabolic Health; Obesity; Lifestyle Modification; Metabolic Syndrome Risk |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-06-11 |
| Primary Completion | 2027-02-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-06-11 with a primary completion date of 2027-02-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to evaluate the effectiveness of an Agentic AI-based personalized dietary management algorithm among adults undergoing health screening. Participants will be assigned to a control group, a static goal AI intervention group, or an adaptive goal AI intervention group and followed for 12 weeks.
Eligibility Criteria
Inclusion Criteria: * Adults aged 20 years or older * Individuals from the general population who underwent a health examination at the Seoul National University Hospital Healthcare System Gangnam Center * Individuals who are capable of independently using a smartphone and operating study-related applications or text messaging functions * Individuals without conditions that significantly interfere with standard dietary management, as specified in the exclusion criteria \[Section 9.2 Exclusion Criteria\] Exclusion Criteria: * Individuals unable to use a smartphone or study-related digital program/application, including those without a smartphone or unable to operate text messaging or application-based functions. * End-stage renal disease or patients currently receiving dialysis * Active cancer or currently undergoing chemotherapy or radiotherapy * Severe heart failure, liver cirrhosis, or hepatic insufficiency accompanied by varices, bleeding, ascites, hepatic encephalopathy, or jaundice * Malabsorption disorders such as Crohn's disease or short bowel syndrome * Poorly controlled hyperthyroidism or hypothyroidism * Diagnosed eating disorders or severe psychiatric disorders * Pregnant or breastfeeding women, or women who may become pregnant during study participation. * Individuals with recent major weight-related interventions or extreme body weight changes within the past 3 months, including:Bariatric surgery such as gastrectomy or gastric bypass surgery Newly initiated anti-obesity pharmacotherapy (e.g., semaglutide/Wegovy, tirzepatide/Mounjaro) * Individuals considered by the investigator to have poor compliance potential or otherwise deemed unsuitable for participation in the clinical study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07638241 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Dietary Behavior; Metabolic Health; Obesity; Lifestyle Modification; Metabolic Syndrome Risk. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07638241 currently recruiting?
Yes, NCT07638241 is actively recruiting participants. Contact the research team at 65390@snuh.org for enrollment information.
Where is the NCT07638241 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT07638241 clinical trial?
NCT07638241 is sponsored by Seoul National University Hospital. The trial plans to enroll 200 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.